Items tagged with Scientific research

Call for applications: Experts in TB research invited to join ERI-TB core group for 2020–2022 (post)

The secretariat of the European Tuberculosis Research Initiative (ERI-TB) at WHO/Europe seeks a maximum of 12 candidates with expertise in tuberculosis (TB) research to succeed current core group members of ERI-TB. According to the terms of reference of ERI-TB, core group members are selected for a period of 2.5–3 years. The first meeting of the newly appointed core group will be held jointly with outgoing members.

Immune system targets vitamin B12 pathway to neutralize TB bacteria (post)

How a recently identified defensive compound called itaconate tricks the bacteria behind tuberculosis.

Six highlights from a week of important TB developments (post)

Researchers, policymakers and activists gathered in Hyderabad, India for the 50th Union World Conference on Lung Health, held on 30 October – 2 November 2019.

Boosting host immune defenses to treat TB (post)

Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to sustain. Moreover, the bacteria often develop drug resistance, and many people harbor multi-drug-resistant strains. In 2018 alone, nearly 1.5 million people died from tuberculosis worldwide.

Chloroquine makes TB bacteria more susceptible to other antimalarial drugs (post)

A team of researchers at the Indian Institute of Science and the Tata Institute of Fundamental Research, both in India, have found that the antimalarial drug chloroquine can make the tuberculosis bacteria more sensitive to other antimalarial drugs. In their paper published in the journal Science Translational Medicine, the group describes their study of the ways that the bacteria behind tuberculosis has become more drug resistant, and what they found.

How an AI solution can design new TB drug regimens (post)

ANN ARBOR—With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments.

T-box structure in bacteria may be target for new antibiotics (post)

Cornell researchers have uncovered the structure of a regulatory mechanism unique to bacteria, opening the door for designing new antibiotics targeted to pathogens.

Latest TB research publications (post)

New treatment to tackle drug-resistant strains of TB could now be possible (post)

New drugs to treat strains of TB which have become resistant to treatment are now a possibility following a ground breaking discovery from the University of Surrey.

TB could be conquered by common painkillers, research reveals (post)

Aspirin could be used to treat the world’s deadliest infectious disease, according to new research conducted by Dr Elinor Hortle at the Centenary Institute in Sydney.